Trials / Completed
CompletedNCT03652844
Use of AAM for Correction of Age Related Volume Deficits in the Face
A Multi-Phase, Prospective, Multi-Center, Single-Blind, Clinical Study to Evaluate the Safety and Efficacy of Allograft Adipose Matrix (AAM) and Diluted AAM for Pre-Jowl and Malar Augmentation to Correct Age Related Volume Deficit in the Face
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Musculoskeletal Transplant Foundation · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. The research will tell whether AAM is effective in maintaining mid-face fullness and whether the appearance of the skin improves after injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | AAM | Subcutaneous injection procedure |
Timeline
- Start date
- 2018-08-27
- Primary completion
- 2019-07-12
- Completion
- 2019-07-12
- First posted
- 2018-08-29
- Last updated
- 2021-05-11
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03652844. Inclusion in this directory is not an endorsement.